A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Extensive unexplored human microbiome diversity revealed by over 150,000 genomes
Journal: Cell (Volume 176, Issue 3, 2019)Authors: Pasolli, Asnicar, Manara, Zolfo, and colleaguesKey Topic: Human microbiome diversity and metagenomic reconstruction What This Paper is About This study used large‑scale metagenomic sequencing to reconstruct 154,723 microbial genomes from…
-
Big Biotech IP Strategy
1. Platform-first patenting (the dominant strategy) Who: Genentech, Amgen, Moderna, Illumina, CRISPR TherapeuticsGoal: Control how innovation happens, not just what is made. Characteristics Example Platforms create optionality—new products without new IP from scratch. 2. Thicketing…
-
Search‑and‑replace genome editing without double‑strand breaks or donor DNA
Journal: NaturePublished: October 21, 2019Authors: Anzalone, Randolph, Davis, Sousa, Koblan, Levy, Chen, Wilson, Newby, Raguram & LiuCitation: Nature **576, 149–157 What the Paper Is About This study describes prime editing, a new form of genome editing that…
BioTech IP Review 